GlassScriptPhysician profile
Brittany D Castro
NPI 1013359918
$3,239.37
in general payments reported to CMS, 2019-2025
33 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $734 · 2022: $347 · 2023: $444 · 2024: $615 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.44 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $620.46 | 2021-2025 | Lifevest |
| Ferring Pharmaceuticals INC. | $254.54 | 2024-2025 | Adstiladrin |
| Amgen INC. | $240.37 | 2021-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $223.49 | 2021-2024 | Farxiga, Andexxa |
| Novartis Pharmaceuticals Corporation | $185.44 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.97 | 2021-2023 | Jardiance |
| Janssen Biotech, INC. | $161.44 | 2025 | Erleada |
| Boston Scientific Corporation | $145.72 | 2022-2025 | Bodyguardian, Ams 700, General - Erectile Dysfunction |
| Bayer Healthcare Pharmaceuticals INC. | $144.68 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $131.55 | 2024-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $109.33 | 2025 | Xiaflex |
| Pfizer INC. | $103.34 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $101.69 | 2021-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $75.00 | 2021-2022 | |
| Abbott Laboratories | $66.84 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $65.45 | 2025 | Provenge |
| Verity Pharmaceuticals INC. | $57.70 | 2025 | Trelstar |
| Abiomed | $42.04 | 2025 | |
| Amarin Pharma, INC. | $35.50 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $35.26 | 2021-2024 | Camzyos |
| Antares Pharma, INC. | $33.38 | 2024 | Xyosted |
| Tempus Ai, INC | $27.49 | 2025 | Xt Cdx |
| Vertex Pharmaceuticals Incorporated | $23.53 | 2025 | |
| Esperion Therapeutics, INC. | $22.53 | 2021 | |
| Accord Healthcare, INC. | $22.05 | 2024 | |
| Immunitybio, INC. | $21.25 | 2025 | |
| Calyxo, INC. | $20.39 | 2024 | Cvac Aspiration System |
| Novo Nordisk INC | $19.42 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $18.47 | 2025 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $17.74 | 2025 | Jatenzo, Eligard |
| Laborie Medical Technologies Corp. | $15.52 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Cvrx, INC. | $14.70 | 2023 | Barostim Neo System |
| Chiesi USA, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.